0001104659-20-120945.txt : 20201103 0001104659-20-120945.hdr.sgml : 20201103 20201103161300 ACCESSION NUMBER: 0001104659-20-120945 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201030 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geshuri Arnnon CENTRAL INDEX KEY: 0001830520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 201283619 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 a4.xml 4 X0306 4 2020-10-30 0 0001477449 Teladoc Health, Inc. TDOC 0001830520 Geshuri Arnnon C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Human Resources Officer Common Stock 2020-10-30 4 A 0 25911 A 25911 D Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Livongo common stock was converted into the right to receive 0.5920 shares of Common Stock and $4.24 in cash, without interest. /s/ Adam C. Vandervoort, as attorney-in-fact 2020-11-03